Anne S. de Groot
Director Ejecutivo en EpiVax, Inc. .
Perfil
Anne S.
de Groot is the founder of EpiVax, Inc. (founded in 1998) and GAIA Vaccine Foundation (founded in 2002).
She currently holds positions as the Director at Epivax Oncology, Inc., Professor at Brown University, and Professor at the University of Rhode Island (since 2013).
Dr. de Groot completed her undergraduate degree at Smith College in 1978 and obtained her doctorate degree from The University of Chicago in 1983.
Cargos activos de Anne S. de Groot
Empresas | Cargo | Inicio |
---|---|---|
EpiVax, Inc.
EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Director Ejecutivo | 01/01/1998 |
Brown University | Corporate Officer/Principal | - |
University of Rhode Island | Corporate Officer/Principal | - |
GAIA Vaccine Foundation | Fundador | 01/01/2002 |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Director/Miembro de la Junta | - |
Formación de Anne S. de Groot.
Smith College | Undergraduate Degree |
The University of Chicago | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
EpiVax, Inc.
EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |
GAIA Vaccine Foundation | |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Anne S. de Groot